Similar Papers

Paper Title
Journal
Date
Author
Abstract 1756: Discovery and characterization of AB680, a potent and selective small-molecule CD73 inhibitor for cancer immunotherapy
Kenneth V Lawson ... Powers P Jay
Cancer Research | VOL. 78
Kenneth V Lawson, et. al.Kenneth V Lawson ... Powers P Jay
01 Jul 2018
Abstract 5921: PH027-1, a potent and selective small-molecule WRN inhibitor that targets MSI-H tumors
Feng Gao ... Pengzhi Zhang
Cancer Research | VOL. 84
Feng Gao, et. al.Feng Gao ... Pengzhi Zhang
22 Mar 2024
Abstract B134: The p38MAPK inhibitor LY2228820 dimesylate, in combination with cytotoxic agents, displays strong antitumor activity in human glioblastoma, multiple myeloma, and other mouse xenograft models.
Susan Pratt ... Michele Dowless
Molecular Cancer Therapeutics | VOL. 10
Susan Pratt, et. al.Susan Pratt ... Michele Dowless
12 Nov 2011
Abstract 4019: Preclinical activity of ELVN-002: A potent, selective, and irreversible HER2 and pan-HER2 mutant small molecule inhibitor for the treatment of HER2 driven malignancies
Monette Aujay ... Qi Wang
Cancer Research | VOL. 83
Monette Aujay, et. al.Monette Aujay ... Qi Wang
04 Apr 2023
View more papers

More From: MedChemComm

Paper Title
Journal
Date
Author
A focused structure-activity relationship study of psoralen-based immunoproteasome inhibitors.
Eva Shannon Schiffrer ... Stanislav Gobec
MedChemComm | VOL. 10
Eva Shannon Schiffrer, et. al.Eva Shannon Schiffrer ... Stanislav Gobec
01 Jan 2019
Contents list
-
MedChemComm | VOL. 10
--
01 Jan 2019
Synthesis and biological evaluation against Leishmania donovani of novel hybrid molecules containing indazole-based 2-pyrone scaffolds.
M El Ghozlani ... P M Loiseau
MedChemComm | VOL. 10
M El Ghozlani, et. al.M El Ghozlani ... P M Loiseau
01 Jan 2019
Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents.
Elena González-Hernández ... M Ángeles Sevilla
MedChemComm | VOL. 10
Elena González-Hernández, et. al.Elena González-Hernández ... M Ángeles Sevilla
01 Jan 2019
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.